RedHill Biopharma (RDHL) Preferred Stock Liabilities (2012)
RedHill Biopharma's (RDHL) quarterly Preferred Stock Liabilities came in at $8.0 million in Q4 2012.
Powered by 
Analysis
RedHill Biopharma (RDHL) Preferred Stock Liabilities (2012) Analysis & Trends
RedHill Biopharma (RDHL) has reported Preferred Stock Liabilities for 1 consecutive years, with $8.0 million the latest figure, recorded in Q4 2012.
- On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $8.0 million in Q4 2012; TTM through Dec 2012 was $8.0 million, a N/A change from a year earlier, with the FY2012 full-year figure at $8.0 million, changed N/A from the prior year.
- Preferred Stock Liabilities was $8.0 million for Q4 2012 at RedHill Biopharma.
- Over five years, Preferred Stock Liabilities peaked at $8.0 million in Q4 2012 and troughed at $8.0 million in Q4 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |